187 related articles for article (PubMed ID: 35979889)
1. Interactions between the intrarenal dopaminergic and the renin-angiotensin systems in the control of systemic arterial pressure.
Vaz de Castro PAS; Jose PA; Simões E Silva AC
Clin Sci (Lond); 2022 Aug; 136(16):1205-1227. PubMed ID: 35979889
[TBL] [Abstract][Full Text] [Related]
2. Intrarenal alterations of the angiotensin-converting enzyme type 2/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats.
Husková Z; Kopkan L; Červenková L; Doleželová Š; Vaňourková Z; Škaroupková P; Nishiyama A; Kompanowska-Jezierska E; Sadowski J; Kramer HJ; Červenka L
Clin Exp Pharmacol Physiol; 2016 Apr; 43(4):438-49. PubMed ID: 26833491
[TBL] [Abstract][Full Text] [Related]
3. The intrarenal renin-angiotensin system in hypertension.
Carey RM
Adv Chronic Kidney Dis; 2015 May; 22(3):204-10. PubMed ID: 25908469
[TBL] [Abstract][Full Text] [Related]
4. Dopamine Receptor D
Zeng C; Armando I; Yang J; Jose PA
Yale J Biol Med; 2023 Mar; 96(1):95-105. PubMed ID: 37009199
[TBL] [Abstract][Full Text] [Related]
5. Dopamine and G protein-coupled receptor kinase 4 in the kidney: role in blood pressure regulation.
Jose PA; Soares-da-Silva P; Eisner GM; Felder RA
Biochim Biophys Acta; 2010 Dec; 1802(12):1259-67. PubMed ID: 20153824
[TBL] [Abstract][Full Text] [Related]
6. Reduction of renal dopamine receptor expression in obese Zucker rats: role of sex and angiotensin II.
Wang X; Li F; Jose PA; Ecelbarger CM
Am J Physiol Renal Physiol; 2010 Nov; 299(5):F1164-70. PubMed ID: 20810614
[TBL] [Abstract][Full Text] [Related]
7. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease.
Kobori H; Nangaku M; Navar LG; Nishiyama A
Pharmacol Rev; 2007 Sep; 59(3):251-87. PubMed ID: 17878513
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive mechanisms of intra-renal dopamine.
Zhang MZ; Harris RC
Curr Opin Nephrol Hypertens; 2015 Mar; 24(2):117-22. PubMed ID: 25594544
[TBL] [Abstract][Full Text] [Related]
9. Physiology and Pathophysiology of the Intrarenal Renin-Angiotensin System: An Update.
Yang T; Xu C
J Am Soc Nephrol; 2017 Apr; 28(4):1040-1049. PubMed ID: 28255001
[TBL] [Abstract][Full Text] [Related]
10. The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases.
Li XC; Zhang J; Zhuo JL
Pharmacol Res; 2017 Nov; 125(Pt A):21-38. PubMed ID: 28619367
[TBL] [Abstract][Full Text] [Related]
11. The renin-angiotensin system and hypertension in autosomal recessive polycystic kidney disease.
Goto M; Hoxha N; Osman R; Dell KM
Pediatr Nephrol; 2010 Dec; 25(12):2449-57. PubMed ID: 20798958
[TBL] [Abstract][Full Text] [Related]
12. The classical and non-classical axes of renin-angiotensin system in Parkinson disease: The bright and dark side of the moon.
Al-Kuraishy HM; Al-Hamash SM; Jabir MS; Al-Gareeb AI; Albuhadily AK; Albukhaty S; Sulaiman GM
Ageing Res Rev; 2024 Feb; 94():102200. PubMed ID: 38237699
[TBL] [Abstract][Full Text] [Related]
13. Role of dopamine in the pathogenesis of hypertension.
Jose PA; Eisner GM; Felder RA
Clin Exp Pharmacol Physiol Suppl; 1999 Apr; 26():S10-3. PubMed ID: 10386248
[TBL] [Abstract][Full Text] [Related]
14. The Relationship between the Intrarenal Dopamine System and Intrarenal Renin-angiotensin System Depending on the Renal Function.
Matsuyama T; Ohashi N; Ishigaki S; Isobe S; Tsuji N; Fujikura T; Tsuji T; Kato A; Miyajima H; Yasuda H
Intern Med; 2018 Nov; 57(22):3241-3247. PubMed ID: 29984779
[TBL] [Abstract][Full Text] [Related]
15. Intrarenal Angiotensin-Converting Enzyme: the Old and the New.
Culver S; Li C; Siragy HM
Curr Hypertens Rep; 2017 Sep; 19(10):80. PubMed ID: 28929450
[TBL] [Abstract][Full Text] [Related]
16. ELABELA antagonizes intrarenal renin-angiotensin system to lower blood pressure and protects against renal injury.
Xu C; Wang F; Chen Y; Xie S; Sng D; Reversade B; Yang T
Am J Physiol Renal Physiol; 2020 May; 318(5):F1122-F1135. PubMed ID: 32174138
[TBL] [Abstract][Full Text] [Related]
17. New frontiers in the intrarenal Renin-Angiotensin system: a critical review of classical and new paradigms.
Zhuo JL; Ferrao FM; Zheng Y; Li XC
Front Endocrinol (Lausanne); 2013; 4():166. PubMed ID: 24273531
[TBL] [Abstract][Full Text] [Related]
18. Dopamine and renal function and blood pressure regulation.
Armando I; Villar VA; Jose PA
Compr Physiol; 2011 Jul; 1(3):1075-117. PubMed ID: 23733636
[TBL] [Abstract][Full Text] [Related]
19. Sodium balance, circadian BP rhythm, heart rate variability, and intrarenal renin-angiotensin-aldosterone and dopaminergic systems in acute phase of ARB therapy.
Isobe-Sasaki Y; Fukuda M; Ogiyama Y; Sato R; Miura T; Fuwa D; Mizuno M; Matsuoka T; Shibata H; Ito H; Ono M; Abe-Dohmae S; Kiyono K; Yamamoto Y; Kobori H; Michikawa M; Hayano J; Ohte N
Physiol Rep; 2017 Jun; 5(11):. PubMed ID: 28576855
[TBL] [Abstract][Full Text] [Related]
20. Effects of dopamine receptor antagonist antipsychotic therapy on blood pressure.
Gonsai NH; Amin VH; Mendpara CG; Speth R; Hale GM
J Clin Pharm Ther; 2018 Feb; 43(1):1-7. PubMed ID: 29119585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
